ARCHIVES

NIH Study Confirms Male Risk Factors For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

New Publications

May 4, 1990